NEW YORK (GenomeWeb) – GenMark Diagnostics said Thursday that it has achieved CE marking under the European In‐Vitro Diagnostic Devices Directive for its ePlex Blood Culture Identification fungal pathogen panel.

The panel is the first in the GenMark Sepsis Solution, which will also include BCID Gram-Positive and Gram-Negative panels, the firm said.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

360Dx reports that the US Centers for Medicare & Medicaid Services would cover next-generation sequencing-based cancer panel tests.

The Washington Post reports that a meteorologist is being considered as presidential science and technology advisor.

In PNAS this week: precision medicine strategy to screen for disease risk, genome evolution in Haemophilus influenzae, and more.

Researchers have developed a PCR-based assay to gauge whether manatees are present in waters.